Trial record 1 of 8 for:    1. RIVER PCI
Previous Study | Return to List | Next Study

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) (RIVER-PCI)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01442038
First received: September 22, 2011
Last updated: February 13, 2015
Last verified: February 2015